In Phase 3 of B-SIMPLE 4’s clinical study published in JAMA Dermatology, Novan’s Berdazimer Gel outperformed the placebo significantly in the treatment of Molluscum. If approved, Berdazimer Gel would become the first prescription medication for the virus. Learn more about this development and explore more details about the study in the publication linked below.
Novan’s Berdazimer Gel Phase 3 Trial Update >